Financials
- Market Capitalization 1.76 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-63.19
ratio cours/chiffre d'affaires
15.2
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2067 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.33 USD | -2.06% | -4.86% | +9.90% | -29.15% | 1.78 B USD | ||
| 2070 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.69 USD | -0.31% | -5.16% | +19.83% | -7.51% | 1.78 B USD | ||
| 2102 | GHRS GH Research PLC - Ordinary Shares | 27.36 USD | +1.41% | -5.39% | -2.88% | +93.22% | 1.70 B USD | ||
| 2106 | FTRE Fortrea Holdings Inc. - Common Stock | 17.72 USD | -3.54% | -2.10% | -7.90% | +71.37% | 1.69 B USD |